| scholarly article | Q13442814 |
| P2093 | author name string | Nai-Feng Liu | |
| Jin-Rong Xia | |||
| Nai-Xun Zhu | |||
| P2860 | cites work | [Hepatic stellate cells and oxidative stress] | Q53544677 |
| Angiotensin II and Aldosterone stimulating NF-kappaB and AP-1 activation in hepatic fibrosis of rat. | Q54581396 | ||
| Association of functional gene polymorphisms of matrix metalloproteinase (MMP)-1, MMP-3 and MMP-9 with the progression of chronic liver disease. | Q54659038 | ||
| IKKα limits macrophage NF-κB activation and contributes to the resolution of inflammation | Q59054264 | ||
| Blockade of RAGE–amphoterin signalling suppresses tumour growth and metastases | Q59084980 | ||
| Up-regulated expression of the receptor for advanced glycation end products in cultured rat hepatic stellate cells during transdifferentiation to myofibroblasts | Q62735381 | ||
| The effect of malotilate on type III and type IV collagen, laminin and fibronectin metabolism in dimethylnitrosamine-induced liver fibrosis in the rat | Q71757398 | ||
| Serum laminin and type IV collagen are accurate markers of histologically severe alcoholic hepatitis in patients with cirrhosis | Q73589294 | ||
| Hepatic stellate cells (HSC): architects of hepatic fibrosis | Q73808998 | ||
| Serum laminin and type III procollagen in chronic hepatitis C. Diagnostic value in the assessment of disease activity and fibrosis | Q73833960 | ||
| Hepatic stellate cells and liver fibrosis | Q81545217 | ||
| The antifibrotic effect of TGF-beta1 siRNAs in murine model of liver cirrhosis | Q83034940 | ||
| Diabetes-associated sustained activation of the transcription factor nuclear factor-kappaB | Q28207628 | ||
| Development and prevention of advanced diabetic nephropathy in RAGE-overexpressing mice | Q28344139 | ||
| Advanced glycation end products cause epithelial-myofibroblast transdifferentiation via the receptor for advanced glycation end products (RAGE) | Q28366662 | ||
| N(epsilon)-(carboxymethyl)lysine adducts of proteins are ligands for receptor for advanced glycation end products that activate cell signaling pathways and modulate gene expression | Q28645594 | ||
| Liver fibrosis | Q29547449 | ||
| Function and activation of NF-kappa B in the immune system | Q29547790 | ||
| Histological grading and staging of chronic hepatitis | Q29619625 | ||
| Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis | Q29619627 | ||
| Inhibitory effects of saikosaponin-d on CCl4-induced hepatic fibrogenesis in rats | Q33787922 | ||
| Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injury | Q33822590 | ||
| Liver fibrosis | Q34005628 | ||
| The biology of the receptor for advanced glycation end products and its ligands | Q34100112 | ||
| Advanced glycation end-products: a review | Q34196489 | ||
| Hepatic stellate cells: role in microcirculation and pathophysiology of portal hypertension | Q34559070 | ||
| Activation of hepatic stellate cells--a key issue in liver fibrosis | Q34565618 | ||
| Liver fibrosis -- from bench to bedside | Q35068035 | ||
| Evaluation of the role of nuclear factor-kappaB signaling in liver injury using genetic animal models | Q36588203 | ||
| Role of ethanol in the regulation of hepatic stellate cell function | Q36655123 | ||
| Enhanced cellular oxidant stress by the interaction of advanced glycation end products with their receptors/binding proteins. | Q38309468 | ||
| Expression of matrix metalloproteinases and their inhibitors during the resorption of schistosome egg-induced fibrosis in praziquantel-treated mice | Q39466912 | ||
| RAGE-mediated MAPK activation by food-derived AGE and non-AGE products | Q40680750 | ||
| CD40 activates NF-kappa B and c-Jun N-terminal kinase and enhances chemokine secretion on activated human hepatic stellate cells | Q40804865 | ||
| Rel/NF-kappa B and I kappa B proteins: an overview | Q41595423 | ||
| Modified synthetic siRNA targeting tissue inhibitor of metalloproteinase-2 inhibits hepatic fibrogenesis in rats | Q42162327 | ||
| Effects of oxymatrine on experimental hepatic fibrosis and its mechanism in vivo | Q42954781 | ||
| Activation of NADPH oxidase by AGE links oxidant stress to altered gene expression via RAGE. | Q43565214 | ||
| Gliotoxin stimulates the apoptosis of human and rat hepatic stellate cells and enhances the resolution of liver fibrosis in rats | Q43720079 | ||
| Markedly elevated levels of plasma advanced glycation end products in patients with liver cirrhosis - amelioration by liver transplantation. | Q43862536 | ||
| Growth hormone increases lung NF-kappaB activation and lung microvascular injury induced by lipopolysaccharide in rats. | Q44642527 | ||
| Inhibition of inhibitor of kappaB kinases stimulates hepatic stellate cell apoptosis and accelerated recovery from rat liver fibrosis. | Q45212249 | ||
| Increased protein glycation in cirrhosis and therapeutic strategies to prevent it. | Q46613224 | ||
| Elevation of Nepsilon-(carboxymethyl)lysine-modified advanced glycation end products in chronic liver disease is an indicator of liver cirrhosis | Q46830346 | ||
| Blockade of receptor for advanced glycation end product (RAGE) attenuates ischemia and reperfusion injury to the liver in mice | Q47214457 | ||
| AGEs and their interaction with AGE-receptors in vascular disease and diabetes mellitus. I. The AGE concept | Q47864019 | ||
| Myofibroblast transdifferentiation of mesothelial cells is mediated by RAGE and contributes to peritoneal fibrosis in uraemia. | Q49082283 | ||
| Activation of the Receptor for Advanced Glycation End Products Triggers a p21 -dependent Mitogen-activated Protein Kinase Pathway Regulated by Oxidant Stress | Q50180621 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 638-661 | |
| P577 | publication date | 2008-04-24 | |
| P1433 | published in | International Journal of Molecular Sciences | Q3153277 |
| P1476 | title | Specific siRNA targeting the receptor for advanced glycation end products inhibits experimental hepatic fibrosis in rats | |
| P478 | volume | 9 |
| Q42223709 | Ameliorative Effects of Nilotinib on CCl4 Induced Liver Fibrosis Via Attenuation of RAGE/HMGB1 Gene Expression and Oxidative Stress in Rat. |
| Q42705850 | CCR5 knockout mice with C57BL6 background are resistant to acetaminophen-mediated hepatotoxicity due to decreased macrophages migration into the liver |
| Q38430098 | Deoxycholic acid-modified polyethylenimine based nanocarriers for RAGE siRNA therapy in acute myocardial infarction |
| Q38258947 | Galectin-3: an emerging all-out player in metabolic disorders and their complications |
| Q38005217 | IL-33 and HMGB1 alarmins: sensors of cellular death and their involvement in liver pathology |
| Q36788544 | Metformin prevents hepatocellular carcinoma development by suppressing hepatic progenitor cell activation in a rat model of cirrhosis. |
| Q35209239 | Molecular pathogenesis of hepatic fibrosis and current therapeutic approaches. |
| Q36193793 | RAGE and tobacco smoke: insights into modeling chronic obstructive pulmonary disease |
| Q43506762 | Receptor for advanced glycation endproducts (RAGE) is a key regulator of oval cell activation and inflammation-associated liver carcinogenesis in mice. |
| Q34734165 | Retracted: High Mobility Group Box-1 Promotes the Proliferation and Migration of Hepatic Stellate Cells via TLR4-Dependent Signal Pathways of PI3K/Akt and JNK |
| Q42957259 | Role of the receptor for advanced glycation end products in hepatic fibrosis |
| Q35870539 | Small interfering RNA targeting receptor for advanced glycation end products suppresses the generation of proinflammatory cytokines |
| Q38995116 | Temporal expression of transporters and receptors in a rat primary co-culture blood-brain barrier model |
| Q36589873 | The controversial role of retinoic acid in fibrotic diseases: analysis of involved signaling pathways |
| Q33633330 | The receptor for advanced glycation end products (RAGE) and the lung |
| Q37857797 | What is the role of the receptor for advanced glycation end products-ligand axis in liver injury? |
Search more.